References
- Allen J, Bradley R. 2011. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. 17(9):827–833. doi:https://doi.org/10.1089/acm.2010.0716.
- Anderson M, Meister A. 1983. Transport and direct utilization of gamma-glutamylcyst(e)ine for glutathione synthesis. Proc Natl Acad Sci USA. 80(3):707–711. doi:https://doi.org/10.1073/pnas.80.3.707.
- Bachhawat A, Kaur A. 2017. Glutathione degradation. Antioxid Redox Signal. 27(15):1200–1216. doi:https://doi.org/10.1089/ars.2017.7136.
- Bhatti J, Nascimento B, Akhtar U, Rhind S, Tien H, Nathens A, da Luz L. 2018. Systematic review of human and animal studies examining the efficacy and safety of N-acetylcysteine (NAC) and N-acetylcystein amid (NACA) in traumatic brain injury: impact on neurofunction outcome and biomarkers of oxidative stress and inflammation. Front Neurol. 8:744. doi:https://doi.org/10.3389/fneur.2017.00744.
- Boyd-Kimball D, Sultana R, Poon HF, Mohmmad-Abdul H, Lynn BC, Klein JB, Butterfield DA. 2005. γ Gamma-glutamylcysteine ethyl ester protection of proteins from Abeta(1-42)-mediated oxidative stress in neuronal cell culture: a proteomics approach. J Neurosci Res. 79(5):707–713. doi:https://doi.org/10.1002/jnr.20393.
- Braidy N, Zarka M, Jugder BE, Welch J, Jayasena T, Chan DKY, Sachdev P, Bridge W. 2019. The precursor to glutathione (GSH), γ-glutamylcysteine (GGC), can ameliorate oxidative damage and neuroinflammation induced by Aβ40 oligomers in human astrocytes. Front Aging Neurosci. 11:177. doi:https://doi.org/10.3389/fnagi.2019.00177.
- Cao P, Braidy N, Zarka M, Welch J, Bridge W. 2015. Therapeutic approaches to modulating glutathione levels as a pharmacological strategy in Alzheimer’s disease. Curr Alzheimer Res. 12(4):298–313. doi:https://doi.org/10.2174/1567205012666150302160308.
- Chandler S, Zarka M, Babu S, Suhas Y, Reddy K, Bridge W. 2012. Safety Assessment of gamma-Glutamylcysteine Sodium Salt. Regul Toxicol Pharmacol. 64(1):17–25. doi:https://doi.org/10.1016/j.yrtph.2012.05.008.
- Clinical Trials. 2020. September. U.S. national library of medicine. Clinical trials. https://clinicaltrials.gov/.
- Courtney-Martin R, Ball R, Pencharz P. 2012. Sulfur amino acid metabolism and requirements. Nutr Rev. 70(3):170–175. doi:https://doi.org/10.1111/j.1753-4887.2011.00466.x.
- Dickinson D, Forman H. 2002. Glutathione in defense and signaling: lessons from a small thiol. Ann NY Acad Sci. 973:488–504. doi:https://doi.org/10.1111/j.1749-6632.2002.tb04690.x.
- Dringen R, Brandmann M, Hohnholt M, Blumrich E. 2015. Glutathione-dependent detoxification processes in astrocytes. Neurochem Res. 40(12):2570–2582. doi:https://doi.org/10.1007/s11064-014-1481-1.
- Fan Y, Wu D, Jin L, Yin Z. 2005. Human glutamylcysteine synthetase protects HEK293 cells against UV-induced cell death through inhibition of c-Jun NH2-terminal kinase. Cell Biol Int. 29(8):695–702. doi:https://doi.org/10.1016/j.cellbi.2005.04.006.
- FDA. 2006, June. Guidance document. Guidance for Industry: Summary Table of Recommended Toxicological Testing for Additives Used in Food: https://www.regulations.gov/docket?D=FDA-2013-S-0610.
- FDA. 2016a, August. 81 FR 54959. Substances generally recognized as safe (final rule). https://www.federalregister.gov/documents/2016/08/17/2016-19164/substances-generally-recognized-as-safe.
- FDA. 2016b, October. Guidance for industry. Draft guidance for industry: new dietary ingredient notifications and related issues. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/draft-guidance-industry-new-dietary-ingredient-notifications-and-related-issues.
- Ferguson G, Bridge W. 2016. Glutamate cysteine ligase and the age-related decline in cellular glutathione: the therapeutic potential of γ-glutamylcysteine. Arch Biochem Biophys. 593:12–23. doi:https://doi.org/10.1016/j.abb.2016.01.017.
- Forman H, Zhang H, Rinna A. 2009. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 30(1–2):1–12. doi:https://doi.org/10.1016/j.mam.2008.08.006.
- Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. 2007. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem. 113(4–5):234–258. doi:https://doi.org/10.1080/13813450701661198.
- Glatt H, Protić-Sabljić M, Oesch F. 1983. Mutagenicity of glutathione and cysteine in the Ames test. Science. 220(4600):961–963. doi:https://doi.org/10.1126/science.6342137.
- Gould R, Pazdro R. 2019. Impact of supplementary amino acids, micronutrients, and overall diet on glutathione homeostasis. Nutrients. 11(5):1056. doi:https://doi.org/10.3390/nu11051056.
- Hagen TM, Wierzbicka GT, Sillau AH, Bowman BB, Jones DP. 1990. Bioavailability of dietary glutathione: effect on plasma concentration. Am J Physiol. 259(4 Pt 1):G524–G529. doi:https://doi.org/10.1152/ajpgi.1990.259.4.G524.
- Hagen T, Aw T, Jones D. 1988. Glutathione uptake and protection against oxidative injury in isolated kidney cells. Kidney Int. 34(1):74–81. doi:https://doi.org/10.1038/ki.1988.147.
- Kwon Y-W, Masutani H, Nakamura H, Ishii Y, Yodoi J. 2003. Redox regulation of cell growth and cell death. Biol Chem. 384(7):991–996. doi:https://doi.org/10.1515/BC.2003.111.
- Le TM, Jiang H, Cunningham GR, Magarik JA, Barge WS, Cato MC, Farina M, Rocha JBT, Milatovic D, Lee E, et al. 2011. γ-Glutamylcysteine ameliorates oxidative injury in neurons and astrocytes in vitro and increases brain glutathione in vivo. Neurotoxicology. 32(5):518–525. doi:https://doi.org/10.1016/j.neuro.2010.11.008.
- Levy E, Anderson M, Meister A. 1993. Transport of glutathione diethyl ester into human cells. Proc Natl Acad Sci USA. 90(19):9171–9175. doi:https://doi.org/10.1073/pnas.90.19.9171.
- Lu S. 2009. Regulation of glutathione synthesis. Mol Aspects Med. 30(1–2):42–59. doi:https://doi.org/10.1016/j.mam.2008.05.005.
- Lu S. 2013. Glutathione synthesis. Biochim Biophys Acta. 1830(5):3143–3153. doi:https://doi.org/10.1016/j.bbagen.2012.09.008.
- Manna SK, Kuo MT, Aggarwal BB. 1999. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene. 18(30):4371–4382. doi:https://doi.org/10.1038/sj.onc.1202811.
- McGill M, Jaeschke H. 2013. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 30(9):2174–2187. doi:https://doi.org/10.1007/s11095-013-1007-6.
- Meister A, Tate S. 1976. Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization. Annu Rev Biochem. 45:559–604. doi:https://doi.org/10.1146/annurev.bi.45.070176.003015.
- Nigwekar S, Kandula P. 2009. N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac Surg. 87(1):139–147. doi:https://doi.org/10.1006/j.anthorasur.2008.09.026.
- Oestreicher J, Morgan B. 2019. Glutathione: subcellular distribution and membrane transport 1. Biochem Cell Biol. 97(3):270–289. doi:https://doi.org/10.1139/bcb-2018-0189.
- Olsson B, Johansson M, Gabrielsson J, Bolme P. 1988. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol. 34(1):77–82. doi:https://doi.org/10.1007/BF01061422.
- Park EY, Shimura N, Konishi T, Sauchi Y, Wada S, Aoi W, Nakamura Y, Sato K. 2014. Increase in the protein-bound form of glutathione in human blood after the oral administration of glutathione. J Agric Food Chem. 62(26):6183–6189. doi:https://doi.org/10.1021/jf501338z.
- Quintana-Cabrera R, Fernandez-Fernandez S, Bobo-Jimenez V, Escobar J, Sastre J, Almeida A, Bolaños JP. 2012. γ γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor. Nat Commun. 3:718. doi:https://doi.org/10.1038/ncomms1722.
- Reed D. 1990. Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol. 30:603–631. doi:https://doi.org/10.1146/annurev.pa.30.040190.003131.
- Reed M, Thomas T, Pavisic J, James S, Ulrich C, Nijhout H. 2008. A mathematical model of glutathione metabolism. Theor Biol Med Model. 5:8–16. doi:https://doi.org/10.1186/1742-4682-5-8.
- Rushworth G, Megson I. 2014. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacol Ther. 141(2):150–159. doi:https://doi.org/10.1016/j.pharmthera.2013.09.006.
- Sandilands E, Bateman D. 2009. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila). 47(2):81–88. doi:https://doi.org/10.1080/15563650802665587.
- Shan Z, Rehm CD, Rogers G, Ruan M, Wang DD, Hu FB, Mozaffarian D, Zhang FF, Bhupathiraju SN. 2019. Trends in dietary carbohydrate, protein, and fat intake and diet quality among US adults, 1999–2016. JAMA. 322(12):1178–1187. doi:https://doi.org/10.1001/jama.2019.13771.
- Skvarc DR, Dean OM, Byrne LK, Gray L, Lane S, Lewis M, Fernandes BS, Berk M, Marriott A. 2017. The effect of N-acetylcysteine (NAC) on human cognition – a systematic review. Neurosci Biobehav Rev. 78:44–56. doi:https://doi.org/10.1016/j.neubiorev.2017.04.013.
- Stark AA, Porat N, Volohonsky G, Komlosh A, Bluvshtein E, Tubi C, Steinberg P. 2003. The role of gamma-gutamyl transpeptidase in the biosynthesis of glutathione. Biofactors. 17(1–4):139–149. doi:https://doi.org/10.1002/biof.5520170114.
- Wang G, Bainbridge D, Martin J, Cheng D. 2011. N-acetylcysteine in cardiac surgery: do the benefits outweigh the risks? A meta-analytic reappraisal. J Cardiothorac Vasc Anesth. 25(2):268–275. doi:https://doi.org/10.1053/j.jcva.2010.04.022.
- Wingler K, Brigelius-Flohé R. 1999. Gastrointestinal glutathione peroxidase. Biofactors. 10(2–3):245–249. doi:https://doi.org/10.1002/biof.5520100223.
- Witschi A, Reddy S, Stofer B, Lauterburg B. 1992. The systemic availability of oral glutathione. Eur J Clin Pharmacol. 43(6):667–669. doi:https://doi.org/10.1007/BF02284971.
- Yang Y, Li L, Hang Q, Fang Y, Dong X, Cao P, Yin Z, Luo L. 2019. γ-Glutamylcysteine exhibits anti-inflammatory effects by increasing cellular glutathione level. Redox Biol. 20:157–166. doi:https://doi.org/10.1016/j.redox.2018.09.019.
- Zarka M, Bridge W. 2017. Oral administration of gamma-glutamylcysteine increases intracellular glutathione levels above homeostasis in a randomized human trial pilot study. Redox Biol. 11:631–636. doi:https://doi.org/10.1016/j.redox.2017.01.014.